RxSight (RXST) Operating Expenses (2020 - 2026)

RxSight (RXST) has 7 years of Operating Expenses data on file, last reported at $41.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 5.96% year-over-year to $41.3 million; the trailing twelve-month figure through Mar 2026 stood at $153.5 million (up 7.02% YoY), and the FY2025 full-year result was $151.2 million, up 11.34% from the prior year.
• Operating Expenses for Q1 2026 stood at $41.3 million, up from $36.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $41.3 million in Q1 2026 and bottomed at $20.3 million in Q1 2022.
• The 5-year median for Operating Expenses is $31.4 million (2024), against an average of $30.4 million.
• The widest annual swing landed in 2022, when Operating Expenses surged 65.98%; it then fell 2.18% in 2025.
• A 5-year view of Operating Expenses shows it stood at $22.4 million in 2022, then increased by 27.19% to $28.5 million in 2023, then jumped by 31.26% to $37.4 million in 2024, then declined by 2.18% to $36.6 million in 2025, then grew by 12.92% to $41.3 million in 2026.
• The last three Operating Expenses figures came in at $41.3 million (Q1 2026), $36.6 million (Q4 2025), and $36.4 million (Q3 2025), per Business Quant data.

Peer Comparison